LIP AND ORAL CAVITY SQUAMOUS CELL CARCINOMAS Guy ANDRY, M.D. Dept of Surgery Institut Jules Bordet, U.L.B. Statements 2008 on Head and Neck Cancer Frankfurt,

Slides:



Advertisements
Similar presentations
Advances and Emerging Therapy for Lung Cancer
Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Clinical Management of Head and Neck Cancer
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Surgical Management of the Neck in Head and Neck Cancer
“Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue” Wojciech K. Mydlarz, M.D.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Surgery in Multimodal Treatment.
Endometrial Cancer Surgical Staging (Role of Lymphadenectomy) Karl Podratz MD PhD FACS.
Early Tongue Cancer Controversies in management of the neck Dr. Serena Wong Queen Elizabeth Hospital.
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
Giuliano Pre-SSO mins ASCO Z mins
Indications for adjuvant radiation therapy with or without lymph nodes in salivary gland cancer Claus Rödel Department of Radiation Therapy University.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Dr. Szekanecz Éva Head and Neck Cancer Eva Szekanecz M.D., Ph.D
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Management of differentiated thyroid cancer Dr. Leung Tak Lun Canice North District Hospital.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.
Hot topics in breast radiotherapy Mark Beresford.
Mauricio A. Moreno, M.D. Assistant Professor Department of Otolaryngology- Head and Neck Surgery University or Arkansas for Medical Sciences Mauricio A.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
AATS Postgraduate Course April 26, 2015 N2 - Current Evidence: Is There Role for Surgery? Is There a Role for Postop Radiation for Surprise N2? Linda W.
Carcinoma Oropharynx.
Melanoma Hai Ho, M.D. Department of Family Practice.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Vulvar Cancer A. Gari MD..
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Management of the Locoregional Recurrence in Well-differentiated Thyroid Carcinoma 陳漢文.
SURGERY FOR NSCLC GREG CHRISTODOULIDES MD, FACS, FCCP, FESTS
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
DAHANCA 16 Planned post-radiation neck dissection vs salvage neck dissection in patients with N2-3 SCC of the head and neck treated with primary radiotherapy.
AJCC Staging Moments AJCC TNM Staging 7th Edition Supraglottic Larynx Case #2 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New.
Management of DCIS KWH Experience Dr. Carmen Ho.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Management of Lymph Node Metastases.
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
Dr. Szekanecz Éva HNC Eva Szekanecz M.D., Ph.D.. CANCERS OF THE HEAD AND NECK MAY ARISE FROM ANY OF THE LINING MEMBRANES OF THE UPPER AERODIGESTIVE TRACT.
Hairy leukoplakia Distinctive oral lesion Seen in immunocompromised patients 80% of patients with hairy leukoplakia have HIV infection.
Clinical Trials Evaluating the Role of Sentinel Node Resection in Patients with Early-Stage Breast Cancer Krag DN et al. Proc ASCO 2010;Abstract LBA505.
STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
General principles for treatment selection Jeffrey Myers MD PhD.
The Neck Jochen A. Werner Marburg, Germany. The Neck in squamous cell carcinoma (HNSCC) in cancer of unknown primary in skin cancer in salivary gland.
External Ear Basosquamous cell carcinoma 1 Instructor: 杜宗陽主任 Reporter: 張廷碩.
Residents’ Journal Club Giao Q. Phan, M.D. September 4, 2014.
Carcinoma of the larynx
Cancer – a substance that causes cancer – a substance that causes cancer –Examples include tobacco smoke, ultraviolet rays, and asbestos Carcinogen.
Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
 It is the sixth most common cancer.  Etiology :male > female(both smoker),age >60y old  Geographical : India 40% because tobacco chewers and spicy.
Carcinoma Vulva & Vagina
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Submandibular gland: Surgical Anatomy Tumors Surgery
NICE GUIDELINES February 2016
Karcinom rektuma- management
Prevention and Early Detection of Oral Cancer For The Public
REGIONAL METASTATIC DISEASE OF THE NECK NECK DISSECTION
Prof.S.M.Haider Faisal Hameed Wahab Kadri
Staging Cancer.
Oral Cancer Louis Collins. May
Prognosis of angiosarcoma at different anatomic sites
Presentation transcript:

LIP AND ORAL CAVITY SQUAMOUS CELL CARCINOMAS Guy ANDRY, M.D. Dept of Surgery Institut Jules Bordet, U.L.B. Statements 2008 on Head and Neck Cancer Frankfurt, 1 st & 2 nd February 2008

5 Years Survival and Cause Specific Survival % LIP ORAL CAVITY ∆ SCSSSCSS St I  15 St II St III  20 St IV After SEER database

LIP CANCER The most common primary (~ 25 % of oral cavity cancer) The most common primary (~ 25 % of oral cavity cancer) ~ 12/ habitants per year USA & Europe ~ 12/ habitants per year USA & Europe Solar-radiation, tobacco smoking, HPV, immunosuppression Solar-radiation, tobacco smoking, HPV, immunosuppression

LIP CANCER SURGERY IS FIRST CHOICE < 2/3 invasion : < 2/3 invasion : –full-thickness pedicled flaps (Abbe or Estlander) > 2/3 invasion : > 2/3 invasion : –musculo mucosalflaps (Camille Bernard…) –free flaps –frontal flap → irradiation in debilitated PTS

LIP CANCER PROGNOSTIC FACTORS Maximum tumor thickness (cf. Martinez- Gimeno Scoring System) Maximum tumor thickness (cf. Martinez- Gimeno Scoring System) Site (upper & commissure more rapid growth and preauricular, submandibular lymph node metastases) Site (upper & commissure more rapid growth and preauricular, submandibular lymph node metastases)

LIP CANCER Scoring system → probability of lymph node invasion Tumor thicknessMartinez-Gimeno Scoring System T stage, Tumor thickness, microvascular, perineural invasion histologic grade of differentiation, presence of inflammatory infiltrate Group I : 0 %of lymph node invasion Group II :21 % Group III :50 % Group IV :67 %

LIP CANCER Mohs micrographic surgery has been successfully used Mohs micrographic surgery has been successfully used –No tumor related deaths or metastases at 5 yrs –All PTS with recurrent disease were successfully salvaged

LIP CANCER T 1 T 2 Surgeryif+ margins + lymph nodes  Adjuvant radiation Radiationif recurrence local regional External beam Brachytherapy  Salvage surgery or both  98 % local control 5 yrs

LIP CANCER There are no published randomized trials on There are no published randomized trials on the use of sequential surgery + radiationthe use of sequential surgery + radiation the use of chemotherapythe use of chemotherapy NB : one preliminary study on super selective intraarterial chemo (CDDP based) in six PTS with T 1, T 2 or local recurrence by Kishi & al, Radiology 213, 1999

FLOOR OF MOUTH CANCER High risk tumors (even in early stages) Proximity to the mandible Proximity to the mandible –Adhesion or invasion (by the alveolar ridge) –Risk of radiation induced bone necrosis No mechanical barrier in soft tissues No mechanical barrier in soft tissues –Blurred vision of margins, Even with high resolution MRI Early lymph node metastases Early lymph node metastases –20 % of occult invasion in T 1 –62 % of occult invasion in T 2 Will develop second primary tumors (~ 20 % in T 1 – T 2 ) “field cancerization” effect of carcinogens Will develop second primary tumors (~ 20 % in T 1 – T 2 ) “field cancerization” effect of carcinogens

FLOOR OF MOUTH CANCER Surgery is generally preferred for T 1 T 2 (primary & necks) Surgery is generally preferred for T 1 T 2 (primary & necks)  + radiationif margins are close or involved if lymph nodes are involved (CR) if mandible is invaded if perineural or/and vascular invasion (or chemo radiation) Role of sentinel node biopsy is under study Role of sentinel node biopsy is under study

FLOOR OF MOUTH CANCER Surgery S 5 yrs T1T1T1T1 95 % T2T2T2T2 86 % Control rate 90 % ← negative margins 62 % ← positive margins Primary ERT Control rate 90 % T1T1T1T1 77 % T2T2T2T2 Neck surgery when invasion depth ≥ 5 mm level I to IIIunilateral for lateral tumors bilateral for anterior/midline

ORAL TONGUE CANCER T 1 T 2 SURGERY Partial glossectomy (negative margins > 1 cm) Partial glossectomy (negative margins > 1 cm) → thickness, depth invasion, perineural spread, vascular invasion Elective neck node dissection Elective neck node dissection -T1T2 T3 T4 N0-T1T2 T3 T4 N0-T1T2 T3 T4 N0-T1T2 T3 T4 N0 N + 6 % 36 %50 %67 % Staging is crucial in defining the postsurgical treatment ERT + CHEMO After Hickx WL. & al, Am J Otolaryngol 1998

ORAL TONGUE CANCER Role of elective neck dissection for T 1 N 0 ? No randomized Trial Retrospective studies remain controversial T 1-2 N 0 ELNTND Yii (RoyalMarsden) REC77 27 % 50 % (p.025) 1999 S 5yrs 75 % 65 % (NS) ELNTND Haddadin (Canniesburn) 1998 S 5yrs % 45 % (p.001) But bias in the initial treatments (various types of surgery, RT or no RT to the primary and/or to the neck)

ELECTIVE VERSUS THERAPEUTIC NECK DISSECTION IN ORAL CAVITY CANCERS Randomized trial 39 ELND36 observations T 1-3 N 0 49 % N + 47 % N + : TND 13 % CR25 % CR DFS 5 yrs 57 % 60 % NS NB : 16 % of second primaries NB : 16 % of second primaries 45 % of deaths met caused by the original tumor After Vandenbrouck & al, Cancer 46 ; 1980

ELECTIVE VERSUS THERAPEUTIC NECK DISSECTION IN ORAL CAVITY CANCERS Randomized trial 30 hemiglossectomy + RND40 hemiglossectomy 10 N +20 N- 23 N+ ↓ 4 contralat + 47 % N+57 % N+ DFS63 %N.S52 % (T 1 : 70 % ; T 2 : 60 %)(T 1 : 64 % ; T 2 : 46 %) After Fakih & al, Am. J. Surg. 158; 1989

ELECTIVE VERSUS THERAPEUTIC NECK DISSECTION IN ORAL CAVITY CANCERS Randomized trial : effect of tumor depth in 51 PTS 21 Hemiglossectomy + ELN30 hemiglossectomy 9 (≥ 4 mm) 12 (< 4 mm) ↓↓ 6 N + (67 %)1 N + (8 %) S 43 % (p < 0.01) S 81 % After Fakih & al, Am. J. Surg. 158; (≥ 4 mm) 9 (< 4 mm) ↓↓↓↓↓↓↓↓ 15 N+ (76 %) 2 N+ (22 %)

LOWER ALVEOLAR RIDGE & RETROMOLAR TRIGONE T 1-2 cancers SURGERY Wide local excision with marginal mandibulectomy SURGERY Wide local excision with marginal mandibulectomy - close proximity to bone - infiltration into the masticator space - nodal involvement RADIATION Adjuvantfor close or positive margins RADIATION Adjuvantfor close or positive margins for lymph node invasion OR if used as first modality

UPPER ALVEOLAR RIDGE & HARD PALATE CANCERS SURGERY SURGERY Resection of part of the palatine process → maxillectomy followed by flap reconstruction or prosthetic rehabilitation -St I (9) St II (19) St III (14) St IV (20) * CSS75 % 46 %36 %11 % - neck dissection in Stage III RADIATION : alone or used for close margins, bulky & infiltrating tumors, nodal spread RADIATION : alone or used for close margins, bulky & infiltrating tumors, nodal spread After Evans & Shah, Am J Surg 1981

BUCCAL MUCOSA CANCERS SURGERY SURGERY transoral resection + check flaps + mandibular resection + maxillectomy - Neck : advocated for T 2 or invasion > 5 mm, muscle St I St II St IIISt IV * 78 % 66 %62 %50 % N 0 necks : 70 % → rec rate if no END or RT : 25 % vs 10 % (p<.05) N + necks : 49 % (no CR : 69 % vs +CR : 24 %) After Diaz & al, Head & Neck free flaps S 5yrs

BUCCAL MUCOSA CANCERS (2) RADIATION : RADIATION : Used primarily for cure of T 1-2 → S3yrs : St I = 85 % ; St II = 63 % * Postop advocated for high risk - margins < 2 mm -perineural invasion -lymph node involvement After Nair & al, Cancer, 1988

CONCLUSIONS (1) Prognostic factors in oral cavity SCCA T size remains an «old timer» T size remains an «old timer» Depth of invasion is more informative Depth of invasion is more informative –as areperineural spread vascular invasion N involvement is a state of emergency from prompt an multidisciplinary aggressive treatment N involvement is a state of emergency from prompt an multidisciplinary aggressive treatment

CONCLUSIONS (2) No neck should not be a cause of debate on what is to be done in a randomized trial No neck should not be a cause of debate on what is to be done in a randomized trial Depth of invasion of the primary Depth of invasion of the primary Status of margins (close, involved, dysplasia,… molecular markers) Status of margins (close, involved, dysplasia,… molecular markers) Perineural spread Perineural spread Vascular invasion Vascular invasion –Shouldbe routinely reported and be the basis of planned treatment